Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Covington
Moodys
Chinese Patent Office
QuintilesIMS
Federal Trade Commission
Fuji
Citi

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019845

« Back to Dashboard

NDA 019845 describes BETOPTIC S, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. Additional details are available on the BETOPTIC S profile page.

The generic ingredient in BETOPTIC S is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
Summary for 019845
Tradename:BETOPTIC S
Applicant:Novartis Pharms Corp
Ingredient:betaxolol hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019845
Mechanism of ActionAdrenergic beta-Antagonists
Medical Subject Heading (MeSH) Categories for 019845
Suppliers and Packaging for NDA: 019845
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845 NDA Alcon Laboratories, Inc. 0065-0246 0065-0246-10 1 BOTTLE, PLASTIC in 1 CARTON (0065-0246-10) > 10 mL in 1 BOTTLE, PLASTIC
BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845 NDA Alcon Laboratories, Inc. 0065-0246 0065-0246-15 1 BOTTLE, PLASTIC in 1 CARTON (0065-0246-15) > 15 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrengthEQ 0.25% BASE
Approval Date:Dec 29, 1989TE:RLD:Yes

Expired US Patents for NDA 019845

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp BETOPTIC S betaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 019845-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
US Department of Justice
QuintilesIMS
Queensland Health
Daiichi Sankyo
Deloitte
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.